🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Graft-Versus-Host Disease

Tissue Immune Landscape of Graft Versus Host Disease After Allogeneic Stem Cell Transplantation (TIL-GVHD) NCT06247150NA1 site📍 Pessac University Hospital, Bordeaux · Tests: Additional blood sample, cGVHD target tissue biopsy Assessment of Infection Activity in Travelers and Migrants Diagnosed With Chronic Schistosomiasis NCT06873308NA8 sites📍 Antwerp📍 Hamburg📍 Bologna IRCCS Sacro Cuore Don Calabria di Negrar · Tests: UCP-LF CAA assay Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment NCT06299683NA1 site📍 Franklin Vanderbilt University Medical Center · Tests: Psychosocial Treatment, Pelvic Floor Physical Therapy Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant NCT06996119Phase 11 site📍 Duarte City of Hope Medical Center · Tests: Biospecimen Collection, Busulfan, Computed Tomography, Cyclophosphamide, Echocardiography Test Efficacy and Safety of FEXUCLUE Tab. In Patients With Acute or Chronic Gastritis NCT06948487n/a1 site📍 Seoul Daewoong Pharmaceutical Co. LTD. Studies on Adsorption International Learning Initiative Global NCT07123909NA1 site📍 Moscow Botkin Hospital · Tests: Patients will undergo a combined hemodialysis and hemosorption procedure. The study cartridge for hemosorption by Jafro… Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease NCT06910969NA2 sites📍 Miami📍 Boston Massachusetts General Hospital · Tests: HORIZONS Intervention, Minimally enhanced usual care Dapagliflozin in Allo-HCT for aGVHD NCT06626737Phase 21 site📍 Suzhou The First Affiliated Hospital of Soochow University · Tests: Dapagliflozin (DAPA) Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor NCT07238712Phase 21 site📍 Saint Petersburg St. Petersburg State Pavlov Medical University · Tests: Ruxolitinib, Abatacept (Orencia) Study of d-MAPPS™ Ophthalmic Solution in Adults With Chronic Ocular Graft-Versus-Host Disease (oGVHD) NCT07776210Phase 35 sites📍 Beverly Hills📍 Beverly Hills📍 Palm Harbor Regenerative Ocular Immunobiologics LLC · Tests: d-MAPPS™ Ophthalmic Solution, Matching vehicle control Quebec Low Back Pain Study: Core Dataset NCT04791891n/a1 site📍 Montreal Laval University MENTOR Wellness Program NCT06148324NA1 site📍 New York NYU Langone Health · Tests: MENTOR Program ICHARUS: Italian Cooperative HemoAdsorption Study for Relief of Uremic Symptoms NCT07522008n/a1 site📍 Cagliari Azienda Ospedaliera Brotzu Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation NCT06008808Phase 11 site📍 St Louis Washington University School of Medicine · Tests: Ruxolitinib, Abatacept Vorinostat for Graft-versus-host Disease (GVHD) Prevention in Non-Malignant Adolescent and Young Adults (AYA) Population NCT06995521Phase 21 site📍 Ann Arbor Sung Won Choi · Tests: Vorinostat Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation NCT06649201n/a1 site📍 Cleveland Case Comprehensive Cancer Center · Tests: Vulvovaginal Symptom Questionnaire, Vaginal Microbiome Evaluation Treatment of Refractory cGVHD by Donor-derived Treg Cell Injection Combined With Recombinant Human Interleukin-2 NCT06920199EARLY Phase 11 site📍 Shanghai Shanghai General Hospital, Shanghai Jiao Tong University Sc… · Tests: Donor-derived Treg cell injection combined with interleukin 2 Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease NCT04744116EARLY Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Cellular Therapy, Ruxolitinib Fecal Microbiota Transplantation for Steroid-Refractory Acute GI GVHD NCT07364617Phase 21 site📍 Taoyuan Chang Gung Memorial Hospital · Tests: Fecal microbiota transplantation (FMT) Novel Therapies for Severe Acute GVHD (Graft-versus-host Disease) NCT07509749Phase 21 site📍 Beijing Daihong Liu · Tests: Ruxolitinib and Methylprednisolone, Methylprednisolone The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation NCT05436418Phase 1, Phase 22 sites📍 Duarte📍 Bethesda National Cancer Institute (NCI) · Tests: Melphalan, Sirolimus, Total Body Irradiation (TBI), Cyclophosphamide, Mycophenolate Mofeti Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders NCT06434363Phase 1, Phase 22 sites📍 Houston📍 Houston M.D. Anderson Cancer Center · Tests: Tafasitamab, Fludarabine phosphate, Cyclophosphamide, Tafasitamab and NK cells Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies NCT05327023Phase 1, Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: donor lymphocyte infusion, Cyclophosphamide, Busulfan, Mycophenolate mofetil, Fludarabine NAVIGATE Kidney: A Multi-level Intervention to Reduce Kidney Health Disparities NCT06810622NA2 sites📍 Denver📍 Albuquerque University of Colorado, Denver · Tests: Community health worker intervention, Standard Care (in control arm) Efficacy of Human Chorionic Gonadotropin in Acute GVHD Treatment NCT06904599Phase 21 site📍 Monterrey Hospital Universitario Dr. Jose E. Gonzalez · Tests: Human chorionic gonadotropin (hCG), Prednisone, Dexamethasone A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD) NCT06619561Phase 226 sites📍 Duarte📍 Los Angeles📍 Orange Deciphera Pharmaceuticals, LLC · Tests: Vimseltinib Therapeutic Effects of Hydrogen on Steroid-refractory/or Steroid-dependent cGVHD NCT02918188Phase 21 site📍 Beijing Navy General Hospital, Beijing · Tests: Hydrogen The Prevalence of Hypoesthesia Related Keratitis in Ocular Graft Vs. Host Disease (GVHD) Patients NCT04700657n/a1 site📍 Indianapolis Indiana University · Tests: corneal sensation test Biomarker-Guided Ruxolitinib for the Prevention of Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation NCT07025538Phase 11 site📍 Duarte City of Hope Medical Center · Tests: Best Practice, Biomarker Analysis, Biospecimen Collection, Questionnaire Administration, Ruxolitinib A Pilot Study to Correlate 4-18F- Fluoro-1-naphthol 18F-4FN PET/CT Imaging With Graft Versus Host Disease Manifestations NCT07325253Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: [18F]-4FN, PET-CT
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy